We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

AusPAR: Besifloxacin hydrochloride

Australian Public Assessment Report

AusPAR

AusPAR: Besifloxacin hydrochloride [PDF, 884.76 KB]

AusPAR: Besifloxacin hydrochloride [Word, 1.7 MB]

Attachment: Product Information: Besifloxacin hydrochloride [PDF, 339.43 KB]

Attachment: Product Information: Besifloxacin hydrochloride [Word, 339.4 KB]

Attachment: Extract from Clinical Evaluation Report: Besifloxacin hydrochloride [PDF, 494.08 KB]

Attachment: Extract from Clinical Evaluation Report: Besifloxacin hydrochloride [Word, 808.18 KB]

Device/Product Name

Besivance

Active ingredients

Besifloxacin hydrochloride

AusPAR Date

3 February 2014

Published

31 March 2014

Submission Number

PM-2012-02740-3-2

Submission Type

New chemical entity

Decision

Approved